These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2252040)

  • 21. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [TWAR infection is a common diagnosis in outpatient clinics].
    Falck G; Engstrand I; Persson K
    Lakartidningen; 1992 Apr; 89(17):1473-6. PubMed ID: 1573935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].
    Zele-Starcević L; Plecko V; Budimir A; Kalenić S
    Acta Med Croatica; 2004; 58(4):329-33. PubMed ID: 15700690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of spiramycin with erythromycin for lower respiratory tract infections.
    De Cock L; Poels R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():159-63. PubMed ID: 3053570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
    Chidiac C; Senneville E; Mouton Y
    Pathol Biol (Paris); 1992 Jun; 40(6):638-45. PubMed ID: 1408383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ofloxacin in lower respiratory tract infections.
    Petermann W
    Infection; 1991; 19 Suppl 7():S372-7. PubMed ID: 1804786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
    Hartinger A; Korting HC; Neubert U; Blaufuss H
    Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae respiratory infection in a child--a case report.
    Lum L; Ngeow YF
    Med J Malaysia; 1992 Dec; 47(4):309-10. PubMed ID: 1303485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin].
    Chuard C; Regamey C
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1913-6. PubMed ID: 2692153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections.
    Harazim H; Wimmer J; Mittermayer HP
    Drugs; 1987; 34 Suppl 1():71-3. PubMed ID: 3481331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chlamydia pneumoniae].
    Ostergaard LJ; Andersen SB; Christiansen G; Andersen PL
    Ugeskr Laeger; 1993 Jun; 155(24):1837-41. PubMed ID: 8317039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood.
    Schmidt SM; Müller CE; Gürtler L; Bruns R; Ballke EH; Wiersbitzky H; Ehlers M; Rose HJ; Wiersbitzky SK
    Klin Padiatr; 2005; 217(1):9-14. PubMed ID: 15640964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population.
    Thom DH; Grayston JT; Wang SP; Kuo CC; Altman J
    Am J Epidemiol; 1990 Aug; 132(2):248-56. PubMed ID: 2372005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Reznik T; Roblin PM; Ramirez J; Summersgill J; Bukofzer S
    J Antimicrob Chemother; 2003 Apr; 51(4):1025-8. PubMed ID: 12654764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral ofloxacin therapy for lower respiratory tract infection.
    Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
    South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Respiratory tract diseases due to Chlamydia pneumoniae].
    Ogawa H; Hashiguchi K; Kazuyama Y; Masuda H; Yamazaki Y
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Mar; 94(3):351-6. PubMed ID: 2040912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.